Bartonellosis Market Report 2026

Bartonellosis Market Overview

• Bartonellosis market size has reached to $1.3 billion in 2025 • Expected to grow to $2.24 billion in 2030 at a compound annual growth rate (CAGR) of 11.3% • Growth Driver: Impact Of Rising Zoonotic Disease Incidences On The Market Growth • Market Trend: Multi-Microbial Phage Therapy Driving Advanced Treatment Options • North America was the largest region in 2025.

What Is Covered Under Bartonellosis Market?

Bartonellosis is a bacterial infection caused by the Bartonella genus, impacting the skin, lymph nodes, and internal organs. Early diagnosis and antibiotic treatment are essential to prevent severe systemic complications and ensure effective disease management. The main disease types of bartonellosis are cat scratch disease (CSD), trench fever, Bartonella endocarditis, and others. Cat scratch disease, caused by Bartonella henselae and transmitted through cat scratches or bites, leads to symptoms such as swollen lymph nodes, fever, and fatigue. It is diagnosed by various diagnostic methods such as polymerase chain reaction (PCR) testing, serological testing, culture methods, and histological testing and treated with several treatments, including antibiotics, antibacterial agents, and supportive care. It is used by various end-users, such as hospitals and clinics, diagnostic laboratories, and others.

What Is The Bartonellosis Market Growth Forecast?

The bartonellosis market size is expected to see rapid growth in the next few years. It will grow to $2.24 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing development of rapid diagnostic assays, rising focus on early intervention in systemic infections, expansion of specialized infectious disease care, growing adoption of precision antibiotic regimens, increasing investment in zoonotic disease research. Major trends in the forecast period include increasing adoption of molecular diagnostic techniques, rising use of pcr-based testing, growing awareness of zoonotic infections, expansion of targeted antibiotic treatment protocols, enhanced focus on early disease identification.

Global Bartonellosis Market Segmentation

1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types 2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing 3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care 4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users Subsegments: 1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications 2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections 3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections 4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis

What Is The Driver Of The Bartonellosis Market?

The rise in incidences of zoonotic diseases is expected to propel the growth of the bartonellosis market going forward. Zoonotic diseases are illnesses that are transmitted from animals to humans, either directly or through vectors. The rise in incidences of zoonotic diseases is due to factors such as increased human-animal interactions, environmental changes, deforestation, global travel, and the spread of pathogens across species. Bartonellosis supports zoonotic diseases by serving as a key example of how bacterial pathogens transmitted through animal vectors, such as fleas, ticks, and lice, can infect humans, leading to a range of clinical manifestations and highlighting the importance of understanding vector-borne disease transmission in public health. For instance, in December 2024, the European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC), a Europe-based public health authority, reported human campylobacteriosis cases rose to 148,181, reflecting a 4.3% year-over-year increase from 139,225 cases in 2022. Similarly, salmonellosis cases climbed to 77,486, marking a 16.9% growth compared to 65,478 cases in 2022. Therefore, the rise in incidences of zoonotic diseases is driving the growth of the bartonellosis industry.

Key Players In The Global Bartonellosis Market

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

Global Bartonellosis Market Trends and Insights

Major companies operating in the Bartonellosis market are focusing on technological advancements, such as multi-microbial phage modulation, to gain a competitive advantage. Multi-microbial phage modulation involves the use of customized phage cocktails that target multiple intracellular pathogens simultaneously, addressing co-infections that frequently complicate Bartonella treatment. For instance, in November 2024, Biologix Center, a US-based biotechnology company, introduced Induced Native Phage Cocktails designed for patients with Bartonella and Babesia co-infections. The therapy features pathogen-specific phage activation, daily adaptive dosing tailored to patient microbial profiles, and enhanced penetration into persistent infection reservoirs. This innovation enables a comprehensive approach to complex co-infections, reduces dependency on conventional antibiotics, and supports precision medicine strategies. By leveraging multi-microbial phage therapy, companies are advancing personalized treatment solutions in the Bartonellosis market while navigating clinical validation and regulatory pathways inherent to emerging biologic therapies.

What Are Latest Mergers And Acquisitions In The Bartonellosis Market?

In October 2024, R.E.D. Laboratories, a Belgium-based biomedical diagnostic company, partnered with IGeneX Inc. to expand access to IGeneX's advanced testing panels. This partnership enables customers across Europe, Africa, and the Middle East to access IGeneX’s specialized Lyme disease and co-infection tests directly through RED Labs. IGeneX Inc. is a US-based provider of bartonellosis diagnostic test kits.

Regional Outlook

North America was the largest region in the bartonellosis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bartonellosis Market?

The bartonellosis market consists of revenues earned by entities by providing services such as medical consultation, symptom management, and vector control and prevention. The market value includes the value of related goods sold by the service provider or included within the service offering. The bartonellosis market includes sales of diagnostic kits, preventive products, pain relievers, and immune support supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bartonellosis Market Report 2026?

The bartonellosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bartonellosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.